Jacqueline E van der Wal
Overview
Explore the profile of Jacqueline E van der Wal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
856
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vos J, Traets J, Qiao X, Seignette I, Peters D, Wouters M, et al.
JCI Insight
. 2024 Nov;
9(21.
PMID: 39513365
Mucosal melanoma (MucM) is a rare cancer with a poor prognosis and low response rate to immune checkpoint inhibition (ICI) compared with cutaneous melanoma (CM). To explore the immune microenvironment...
2.
Piek M, de Boer J, Van Duijnhoven F, van der Wal J, Vriens M, van Leeuwaarde R, et al.
BMC Cancer
. 2022 Sep;
22(1):1018.
PMID: 36163009
Background: Breast cancer (BC) and differentiated thyroid cancer (TC) are two common cancer types with the highest incidence in women. BC and TC can develop synchronous or metachronous and the...
3.
Schreuder W, van der Wal J, de Lange J, van den Berg H
Bone
. 2021 Mar;
149:115935.
PMID: 33771761
The majority of giant cell lesions of the jaw present as a solitary focus of disease in bones of the maxillofacial skeleton. Less frequently they occur as multifocal lesions. This...
4.
Hoefsmit E, Rozeman E, Van T, Dimitriadis P, Krijgsman O, Conway J, et al.
J Immunother Cancer
. 2020 Dec;
8(2).
PMID: 33262254
Background: The profound disparity in response to immune checkpoint blockade (ICB) by cutaneous melanoma (CM) and uveal melanoma (UM) patients is not well understood. Therefore, we characterized metastases of CM...
5.
Franke V, Smeets P, van der Wal J, van Akkooi A
Melanoma Res
. 2020 Jun;
30(6):548-551.
PMID: 32516238
Talimogene laherparepvec (T-VEC) is an oncolytic virus, approved for the treatment of stage IIIb-IVM1a melanoma with injectable disease (cutaneous, subcutaneous or lymphatic). It is a modified herpes simplex virus type...
6.
Wachters J, Kop E, Slagter-Menkema L, Mastik M, van der Wal J, van der Vegt B, et al.
Laryngoscope
. 2020 Feb;
130(12):2825-2832.
PMID: 32065407
Background: In early stage laryngeal squamous cell carcinoma (LSCC) radiotherapy with curative intent is a major treatment modality. TNM classification is used to define patients eligible for radiotherapy. Studies in...
7.
Rozeman E, Prevoo W, Meier M, Sikorska K, Van T, van de Wiel B, et al.
Melanoma Res
. 2020 Jan;
30(3):252-260.
PMID: 31895753
Approximately, 50% of patients with uveal melanoma develop distant metastasis for which no standard therapy is established. In contrast to cutaneous melanoma, the anti-CTLA-4 antibody ipilimumab showed no clinical activity...
8.
de Veij Mestdagh P, Schreuder W, Vogel W, Donswijk M, van Werkhoven E, van der Wal J, et al.
BMC Cancer
. 2019 Nov;
19(1):1110.
PMID: 31727019
Background: The majority of patients with head and neck squamous cell carcinoma (HNSCC) receive bilateral elective nodal irradiation (ENI), in order to reduce the risk of regional failure. Bilateral ENI,...
9.
Elbers J, Al-Mamgani A, Tesseslaar M, van den Brekel M, Lange C, van der Wal J, et al.
Radiother Oncol
. 2019 Sep;
142:79-84.
PMID: 31563412
Background And Purpose: Radiotherapy (RT) with cetuximab is an alternative for advanced-stage head and neck squamous cell carcinoma (HNSCC) patients who are unfit for cisplatin treatment. As 5-year overall survival...
10.
Knijp J, van der Wal J, Crijns M
Ned Tijdschr Geneeskd
. 2019 Sep;
163.
PMID: 31483587
A 74-year-old woman was referred to the dermatologist because of erythema on the chest which had not improved with topical corticosteroids. She had a medical history of papillary thyroid carcinoma....